Status:
COMPLETED
Algorithm Using a Rapid Diagnostic Test for the Management of Childhood Febrile Diseases.
Lead Sponsor:
Institut de Recherche en Sciences de la Sante, Burkina Faso
Conditions:
Antimicrobial Resistance
Eligibility:
All Genders
2-59 years
Phase:
NA
Brief Summary
In Sub-Saharan Africa (SSA), fever remains a major public health problem in children. The introduction of malaria rapid diagnostic tests (RDTs) in routine healthcare has greatly improved the managemen...
Detailed Description
Background In Sub-Saharan Africa (SSA), febrile illnesses remains a major public health problem in children. The introduction of malaria rapid diagnostic tests (RDTs) in routine healthcare has greatly...
Eligibility Criteria
Inclusion
- Children from 2 to 59 months of age;
- Acute fever (axillary temperature over or equal to 37.5°) or history of fever within the past 7 days;
- Available to return for the follow-up visit at the health facility on day 7 (±2).
- Written informed consent obtained from parents/legal guardian.
Exclusion
- Children less than 2 months or over 59 months;
- Presence of signs and symptoms of severe infections;
- Children with chronic febrile infections.
Key Trial Info
Start Date :
February 28 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 30 2023
Estimated Enrollment :
1176 Patients enrolled
Trial Details
Trial ID
NCT05285657
Start Date
February 28 2022
End Date
November 30 2023
Last Update
June 17 2024
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Institut de Recherche en Sciences de la Santé-Clinical Research Unit of Nanoro
Nanoro, Boulkiemde, Burkina Faso, 11 BP 218 Ouaga CMS 11
2
Health District of Nanoro
Nanoro, Boulkiemde, Burkina Faso